HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1

Literature (3)

Literature for OMIM 170400: HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1

Xenbase Articles:
(

Denotes literature images)

Stac3 enhances expression of human CaV1.1 in Xenopus oocytes and reveals gating pore currents in HypoPP mutant channels., Cannon SC,Wu F,Quinonez M,DiFranco M, J Gen Physiol. March 5, 2018; 150(3):1540-7748.
A novel ATP1A2 mutation in a patient with hypokalaemic periodic paralysis and CNS symptoms., Sampedro Castañeda M,Zanoteli E,Scalco RS,Marques Caldas V,Conti Reed U,da Silva AMS,O'Callaghan B,Bugiardini E,Sud R,McCall S,Poulsen H,Männikkö R,Scaramuzzi V,Phadke R,Hanna MG,Matthews E, Brain. December 1, 2018; 141(12):1460-2156.
Evaluation of mutant muscle Ca2+ channel properties using two different expression systems., Allard B, J Gen Physiol. July 2, 2018; 150(7):1540-7748.

A novel ATP1A2 mutation in a patient with hypokalaemic periodic paralysis and CNS symptoms., Sampedro Castañeda M,Zanoteli E,Scalco RS,Marques Caldas V,Conti Reed U,da Silva AMS,O'Callaghan B,Bugiardini E,Sud R,McCall S,Poulsen H,Männikkö R,Scaramuzzi V,Phadke R,Hanna MG,Matthews E, Brain. December 1, 2018; 141(12):1460-2156.